Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of using buffered formulations of exendin (9-39)

Methods of using buffered formulations of exendin (9-39)

US Patent 11738086 · Granted Aug 29, 2023

Estimated economic value: $1,111,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of hyperinsulinemic hypoglycemia with GLP-1 antagonist exendin(9-39)2025
Treatment of hyperinsulinemic hypoglycemia with GLP-1 antagonist exendin(9-39)2025
Treatment of post-bariatric hypoglycemia with exendin (9-39)2024
Treatment of post-bariatric hypoglycemia with exendin (9-39)2024
Treatment of post-bariatric hypoglycemia with GLP-1 antagonists2023
Treatment of post-bariatric hypoglycemia with GLP-1 antagonists2023
Treatment of post-bariatric hypoglycemia with exendin (9-39)2023
Treatment of post-bariatric hypoglycemia with exendin (9-39)2023
Methods for the treatment of non-alcoholic steatohepatitis2023
Camera optical lens including six lenses of +−−−+− refractive powers2022
Camera optical lens including six lenses of +−−++−refractive powers2022
Camera optical lens including seven lenses of ++−−−+− or ++−−−++ refractive powe2022